跳至主要内容
临床试验/CTIS2023-510198-32-00
CTIS2023-510198-32-00进行中(未招募)1 期

Zoledronate Early to Hip Fractures Patients – safe and effective? A Randomized controlled double-blinded treatment strategy trial on Zoledronate in hip fracture patients: The ZEBRA trial

Oslo University Hospital HF0 个研究点目标入组 300 人开始时间: 2024年5月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • One low energy hip fracture, Surgery within 72 hours, >50 years old -Women age 50-60 must be postmenopausal or not pregnant, Acceptable kidney function (estimated GFR >35) and calcium levels, Fit to complete the follow-up judged by the recruiting physician, Signed informed consent by the patient or the next of kin

排除标准

  • Metal in the opposite hip, More than one acute fracture (concomitant fracture in addition to hip fracture), Anti-osteoporosis treatment with bisphosphonates, denosumab, teriparatid, abaloparatid or romosozumab within the last 10 years, Glucocorticoid therapy, treatment with gnRH-analogs, aromatase-inhibitors, primary skeletal cancer or metastasis to the skeleton, Too sick to receive treatment with zoledronate judged by the recruiting or treating physician, Any other contraindication listed on the SmPC of the IMP(s) including pregnancy, Participating in another trial that might affect the current study

研究者

发起方
Oslo University Hospital HF

相似试验

进行中(未招募)
1 期
Zoledronate early to patients after hip surgery-safe and effective?Osteoporosis
EUCTR2020-000638-17-NOOslo University Hospital300
已完成
4 期
Zoledronate Early to Hip Fracture Patients - Safe and Effective?Hip FracturesOsteoporosis
NCT05025293Lene Bergendal Solberg228
进行中(未招募)
4 期
Efficacy of Zoledronate in fracture prevention in osteopenic postmenopausal women.
ACTRN12609000593235Professor Ian Reid2,000
已完成
3 期
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesMetastatic CancerProstate Cancer
NCT00079001Alliance for Clinical Trials in Oncology645
进行中(未招募)
1 期
Zoledronate against fractures in children with cerebral palsycerebral palsy, osteopenia, fractureMedDRA version: 20.0Level: PTClassification code 10049088Term: OsteopeniaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 15.1Level: HLTClassification code 10034157Term: Pathological fractures and complicationsSystem Organ Class: 100000005035MedDRA version: 20.0Level: PTClassification code 10049904Term: Osteoporosis prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10021740Term: Infantile cerebral palsySystem Organ Class: 100000012650MedDRA version: 20.0Level: PTClassification code 10006002Term: Bone painSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 20.0Level: LLTClassification code 10013522Term: Disuse osteoporosisSystem Organ Class: 100000018618
EUCTR2014-002118-21-DKRanders Regional Hospital